Samrat Pharmachem standalone net profit declines 67.44% in the December 2022 quarter
Sales rise 51.77% to Rs 83.99 crore
Net profit of Samrat Pharmachem declined 67.44% to Rs 2.10 crore in the quarter ended December 2022 as against Rs 6.45 crore during the previous quarter ended December 2021. Sales rose 51.77% to Rs 83.99 crore in the quarter ended December 2022 as against Rs 55.34 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales83.9955.34 52 OPM %4.0715.58 -PBDT2.948.72 -66 PBT2.788.57 -68 NP2.106.45 -67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 15 2023 | 7:40 AM IST